Posters and Presentations
Each year, the ARUP Institute for Clinical and Experimental Pathology® presents at more than 200 conferences, workshops, annual meetings, and symposiums for several national and international organizations. Recent posters and presentations are listed below.
Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC)/International Congress of Chemotherapy and Infection (ICC)
San Diego, CA, September 17–21, 2015
Fisher MA. Advanced applications of MALDI-TOF in clinical microbiology: strain typing and custom databases.
Boyd NK, Lee GC, Frei CR, Fisher MA. Antimicrobial susceptibilities of gram negative anaerobic isolates collected nationwide, 2002–2013.
American Society of Histocompatibility and Immunogenetics (ASHI)
Savannah, GA, September 28–October 2, 2015
Profaizer T, Delgado J, Kumanovics A—Poster
Profaizer T, Lazar-Molnar E, Delgado J, Kumanovics A. Comparing fragment size with read-length and their effect on HLA genotyping by next-generation sequencing (NGS).
30th International Papillomavirus Conference & Clinical Workshop (HPV 2015)
Lisbon, Portugal, September 17–21, 2015
Pyne M, Tardif K, Schlaberg R—Poster
Pyne M, Tardif K, Allen A, Davies C, Adelman M, Janat-Amsbury M, Schlaberg R. Clinical comparison of SurePath and PreservCyt preservatives with Cobas and Hybrid Capture 2 HPV tests in a colposcopy population.
Cancer Genomics Consortium (CGC)–Cytogenomics Array Group CNV Database (CAGdb)
Denver, CO, August 3–5, 2015
Paxton C, Rowe LR, South ST—Presentation
Paxton C, Rowe LR, South ST. Validation of a modified OncoScan® protocol for use in a clinical laboratory.
Association of Medical and Laboratory Immunologists (AMLI)
New Orleans, LA, August 14–17, 2015
Taggart B, Jaskowski TD, Tebo AE—Poster
Malohifoou F, Cromar A, Singh J, Taggart B, Jaskowski TD, Tebo AE. A comparison of anti-nuclear antibody detection using three enzyme immunoassays and indirect immunofluorescence antibody tests.
Haven TR, Tebo AE—Poster
Haven TR, Knapp D, Outly TK, Tebo AE. Detection of aquaporin-4 receptor autoantibody in cerebrospinal fluid by recombinant cell immunofluorescence.
Jaskowski TD, Tebo AE—Poster
Jaskowski TD, Mahler M, Albesa R, Zohoury N, Bentow C, Tebo AE. Evaluation of the NOVA Dot for the detection of anti-TH/TO antibodies.
Peterson LK, Lozier BK, Hill HR. Optimizing the dihydrorhodamine (DHR) neutrophil oxidative burst assay to decrease the number of indeterminate results.
Pavlov IY, Delgado JC—Poster
Pavlov IY, Delgado JC. Reporter-gene assay for measurement of functional activity of infliximab and neutralizing anti-infliximab antibodies: results of two years of clinical laboratory use.
David W. Smith Malformation and Morphogenesis Workshop
St. Michaels, MD, August 14–19, 2015
Swensen J, Vaughn C—Poster
Stevenson DA, Swensen J, Hartung AM, Uriz IE, Lapin M, Carey JC, Yi P, Vaughn C, Dobrowolski SF, Larsen MR, Calhoun A, Andresen BS. HRAS p.G12V mutations in Costello syndrome.
European Congress of Clinical Chemistry and Laboratory Medicine
Paris, France, June 21–25, 2015
Signorelli HN, McCord L, Frank EL. Reference intervals for urinary porphyrins and porphobilinogen derived from an American laboratory database.
Hereditary Hemorrhagic Telangiectasia (HHT)
Captiva, FL, June 11–14, 2015
Wooderchak-Donahue WL, Lewis T, Bayrak-Toydemir P—Poster
Wooderchak-Donahue WL, McDonald J, VanSant-Webb C, Lewis T, Stevenson DA, Bayrak-Toydemir P. Molecular diagnostics in the new era: clinical utility of a next-generation sequencing panel in the diagnosis of HHT.
Clinical Immunology Society (CIS)
Houston, TX, April 9–12, 2015
Kumanovics A, Nee Lee Y, Ujhazi B, Chen K, MacArthur D, Notarangelo LD, Walter JE. Estimated disease incidence of RAG1 mutation by querying the Exome Aggregation Consortium.
Australasian Society of Cytogeneticists and the Molecular Genetics Society of Australasia
Auckland, New Zealand, April 10–12, 2015
South ST. Detection of copy number alterations, ploidy, and loss of heterozygosity across the genome in FFPE specimens—utility for diagnosis and treatment with comparison to FISH-based and as a complement to sequencing assays.
South ST. Discussion of unusual cases—it's never boring to be looking at the whole genome.
European Society of Clinical Microbiology and Infectious Disease (ECCMID)
Copenhagen, Denmark, April 25–28, 2015
Couturier B, Couturier M—Poster
Couturier B, Jensen R, Case K, Heffron M, Gubler E, Couturier M. An analytical evaluation of Parasep stool concentrators compared to conventional methodologies for ova and parasite fecal concentration.
Stephenson J, Fisher MA, Neil J, Yip P, Cardasis H, Cherkassky A, Ravela S, Ritamo I, Valmu L, Damsbo M, Grist R, Eugen D. Proteomic approach to the detection of penicillin binding protein 2a (PBP2a) in Staphylococcus aureus.
Pan American Society for Clinical Virology (PASCV)
Daytona, FL, April 26–28, 2015
Mallory MA, Hillyard DR—Poster
Mallory MA, Lucic DX, Ebbert MTW, Cloherty GA, Toolsie D, Hillyard DR. Evaluation of the Abbott Realtime HCV Genotype Plus (GT PLUS) Ruo assay with reference to core and NS5B sequencing.
Pyne MT, Hillyard DR—Poster
Pyne MT, Hillyard DR. Validation of a quantitative RT-PCR assay for hepatitis E virus.
Pyne MT, Hillyard DR—Poster
Pyne MT, Hillyard DR. Validation of the Roche CAP/CTM HIV qualitative assay, version 2.
International Symposium on Myelodysplastic Syndromes (MDS)
Washington, DC, April 29–May 2, 2015
Andersen EF, Salama ME, Sederberg MC, Toydemir RM, Rodgers GM, South ST—Poster
Andersen EF, Salama ME, Sederberg MC, Toydemir RM, Kovacsovics TJ, Parker CJ, Rodgers GM, Shami PJ, Deininger MW, South ST. Evaluating the clinical utility of peripheral blood samples for molecular evaluation of MDS by SNP-A.